Journal profile · Psychiatry
European Neuropsychopharmacology
ISSN 0924-977X · eISSN 1873-7862 · Elsevier · NETHERLANDS · Monthly · Founded 1990
European Neuropsychopharmacology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.05; hybrid open access; APC about USD 3,000; median 83 days to acceptance (95 articles, last 24 months); community-reported acceptance: moderate; 620 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
European Neuropsychopharmacology is published by Elsevier and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Schizophrenia research and treatment, Treatment of Major Depression and Bipolar Disorder and Treatment, together about 24.5% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
An Official Journal of the European College of Neuropsychopharmacology European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.European Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology (ECNP).Electronic usage: An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.Average monthly article downloads for this journal: 29,000
From the journal's Aims & Scope
Research area (LetPub): Psychiatry
Editor-in-chief Eduard VietaPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 10, Spain 10, Germany 9, Netherlands 6, United States 5 (68 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine8.8%
- Treatment of Major DepressionMedicine8.2%
- Bipolar Disorder and TreatmentMedicine7.5%
- Tryptophan and brain disordersNeuroscience7.3%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience7.2%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.8%
- Stress Responses and CortisolNeuroscience6.1%
- Attention Deficit Hyperactivity DisorderMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Psychiatry | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
| Minor | Psychiatry | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Clinical Neurology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Psychiatry | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.05LetPub ·
- Impact factor (publisher)
- 8.1Publisher website ·
- CiteScore 2026-06
- 13.2LetPub ·
- CiteScore (publisher)
- 13.2Publisher website ·
- SJR 2026-06
- 2.33LetPub ·
- SNIP 2026-06
- 1.73LetPub ·
- h-index
- 100LetPub ·
- h-index
- 159OpenAlex ·
- i10-index
- 3,226OpenAlex ·
- 2-year mean citedness
- 0.97OpenAlex ·
- Self-citation rate
- 7.4%LetPub ·
- Share of gold OA articles
- 59.11%LetPub ·
Volume
- Articles per year
- 56LetPub ·
Articles by year OpenAlex count · 36,040 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 766 | 589 | 76 |
| 2025 | 620 | 108 | 449 |
| 2024 | 687 | 115 | 1,492 |
| 2023 | 657 | 103 | 2,322 |
| 2022 | 711 | 92 | 2,305 |
| 2021 | 1,553 | 194 | 4,832 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
83 daysMedian, submission to acceptance · P25–P75 19 days – 130 days
- Acceptance to online
- median 11 days (95 articles)
- Submission to online
- median 100 days
- Sample
- 95 articles with submission and acceptance dates (310 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher)
- 15%Publisher website ·
- First decision after review
- 45 daysPublisher website ·
- Submission to acceptance
- 33 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,000 / EUR 2,810 / GBP 2,400 / JPY 372,090 | — | — | |
| Publisher website | USD 3,450 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Colour charges
- Charged; see the journal's website for the amount
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 6,500 words
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted1, with length limits
- short communicationigures) and no more than 80 references; Short Communications: max 2500 words and no more than 25 references; Reviews on specialised topimain text ≤ 2,500 words
Policy excerpts from the journal's websiteConflicts of interest, License & copyright, Open access
- Conflicts of interest Author Disclosure
Role of Funding Source. Authors are kindly requested to briefly describe the role of the study sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such involvement, authors should so state. eg, Funding for this study was provided by NIMH Gr…
Source ↗Publisher website ·- License & copyright Copyright Transfer
Upon acceptance of an article, you will be asked to transfer copyright. This transfer will ensure the widest possible dissemination of information. If excerpts from other copyrighted works are included in the submission, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: co…
Source ↗Publisher website ·- Open access Open Access
Article Publishing Charge (APC): USD 3,450 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Monthly
- Founded
- 1990
- ISSN
- 0924-977X
- Electronic ISSN
- 1873-7862
- Society / sponsor
- European College of Neuropsychopharmacology
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about European Neuropsychopharmacology
What CAS zone is European Neuropsychopharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Neuropsychopharmacology is in Zone 2 of Medicine, and in Zone 2 of the minor category Clinical Neurology / Neurosciences / Pharmacology & Pharmacy / Psychiatry. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Neuropsychopharmacology?
The latest impact factor listed by LetPub is 8.05; CiteScore 13.2, h-index 159.
How long does peer review take at European Neuropsychopharmacology?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 19–130 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 15%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Neuropsychopharmacology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Manuscript length: ≤ 6,500 words; Reference style: Author–date; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Neuropsychopharmacology based?
Of the 68 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (10), Spain (10) and Germany (9). Counted from the institutions listed on the board page; for reference only.
Which databases index European Neuropsychopharmacology?
According to LetPub and DOAJ records, European Neuropsychopharmacology is indexed in SCIE and Scopus.
Is European Neuropsychopharmacology open access, and what is the APC?
European Neuropsychopharmacology is a hybrid journal. For open-access publication: APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .